Carbetapentane / Guaifenesin Dosage
Medically reviewed by Drugs.com. Last updated on Aug 3, 2023.
Applies to the following strengths: 8 mg-200 mg; 7.5 mg-150 mg/5 mL; 60 mg-600 mg; 20 mg-75 mg/5 mL; 7.5 mg-200 mg/5 mL; 5 mg-1000 mg; 60 mg-1000 mg; 20 mg-100 mg/5 mL; 10 mg-100 mg/5 mL; 60 mg-1200 mg; 60 mg-900 mg
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Cough
Carbetapentane-guaifenesin 10 mg-100 mg/5 mL oral liquid:
5 to 10 mL orally every 4 to 6 hours not to exceed 6 doses daily.
Carbetapentane-guaifenesin 5 mg-1000 mg oral tablet, extended release, Carbetapentane-guaifenesin 60 mg-1000 mg oral tablet, extended release and Carbetapentane-guaifenesin 60 mg-1200 mg oral tablet, extended release: 1 tablet orally every 12 hours not to exceed 2 tablets daily.
Carbetapentane-guaifenesin 7.5 mg-150 mg/5 mL oral syrup:
10 mL orally every 4 to 6 hours not to exceed 6 doses daily.
Carbetapentane-guaifenesin 7.5 mg-200 mg/5 mL oral suspension, extended release:
10 mL orally every 12 hours.
Carbetapentane-guaifenesin 8 mg-200 mg oral capsule:
2 capsules orally every 4 to 6 hours.
Carbetapentane-guaifenesin 20 mg-100 mg/5 mL oral syrup:
10 mL orally every 4 to 6 hours.
Carbetapentane-guaifenesin 20 mg-75 mg/5 mL oral liquid:
5 to 10 mL orally every 4 to 6 hours.
Carbetapentane-guaifenesin 30 mg-400 mg oral capsule, extended release:
1 to 2 capsules orally every 12 hours not to exceed 4 tablets daily.
Carbetapentane-guaifenesin 60 mg-600 mg oral tablet, extended release:
1 to 2 tablets orally every 12 hours not to exceed 4 tablets daily.
Usual Pediatric Dose for Cough
Carbetapentane-guaifenesin 10 mg-100 mg/5 mL oral liquid:
6 to 11 years: 5 mL orally every 4 to 6 hours not to exceed 6 doses daily.
12 years or older: 5 to 10 mL orally every 4 to 6 hours not to exceed 6 doses daily.
Carbetapentane-guaifenesin 5 mg-1000 mg oral tablet, extended release, and Carbetapentane-guaifenesin 60 mg-1000 mg oral tablet, extended release:
6 to 11 years: 0.5 tablet orally every 12 hours not to exceed 1 tablet daily.
12 years or older: 1 tablet orally every 12 hours not to exceed 2 tablets daily.
Carbetapentane-guaifenesin 7.5 mg-150 mg/5 mL oral syrup:
6 to 11 years: 5 mL orally every 4 to 6 hours not to exceed 6 doses daily.
12 years or older: 10 mL orally every 4 to 6 hours not to exceed 6 doses daily.
Carbetapentane-guaifenesin 7.5 mg-200 mg/5 mL oral suspension, extended release:
2 to 4 years: 2.5 mL orally every 12 hours.
5 to 11 years: 5 mL orally every 12 hours.
12 years or older: 10 mL orally every 12 hours.
Carbetapentane-guaifenesin 8 mg-200 mg oral capsule:
6 to 11 years: 1 capsule orally every 4 to 6 hours.
12 years or older: 2 capsules orally every 4 to 6 hours.
Carbetapentane-guaifenesin 20 mg-100 mg/5 mL oral syrup:
2 to 5 years: 2.5 mL orally every 4 to 6 hours.
6 to 11 years: 5 mL orally every 4 to 6 hours.
12 years or older: 10 mL orally every 4 to 6 hours.
Carbetapentane-guaifenesin 20 mg-75 mg/5 mL oral liquid:
2 to 5 years: 2.5 mL orally every 4 to 6 hours.
6 to 11 years: 5 mL orally every 4 to 6 hours.
12 years or older: 5 to 10 mL orally every 4 to 6 hours.
Carbetapentane-guaifenesin 30 mg-400 mg oral capsule, extended release:
6 to 11 years: 1 capsule orally every 24 hours not to exceed 1 capsule daily.
12 years or older: 1 to 2 capsules orally every 12 hours not to exceed 4 capsules daily.
Carbetapentane-guaifenesin 60 mg-1200 mg oral tablet, extended release:
12 years or older: 1 tablet orally every 12 hours not to exceed 2 tablets daily.
Carbetapentane-guaifenesin 60 mg-600 mg oral tablet, extended release:
6 to 11 years: 0.5 to 1 tablet orally every 12 hours not to exceed 2 tablets daily.
12 years or older: 1 to 2 tablets orally every 12 hours not to exceed 4 tablets daily.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dialysis
Data not available
More about carbetapentane / guaifenesin
- Check interactions
- Compare alternatives
- Side effects
- Drug class: upper respiratory combinations
- En español
Patient resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.